Report of foreign issuer [Rules 13a-16 and 15d-16]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Total net sales $ 136,046 $ 144,050
Cost of revenues    
Total cost of sales 75,807 80,153
Gross profit 60,239 63,897
Operating expenses    
Research and development, net 18,792 23,977
Selling, general and administrative 53,851 64,373
Total operating expenses 72,643 88,350
Operating loss (12,404) (24,453)
Financial income (expenses), net 1,473 1,217
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total (10,931) (23,236)
Income tax benefit (expenses) 455 716
Share in net profits (losses) of associated companies 1,668 2,031
Net loss $ (13,054) $ (25,983)
Earnings Per Share, Basic $ (0.18) $ (0.37)
Weighted average shares outstanding - diluted 71,967 69,993
Comprehensive Loss    
Net loss attributable to non-controlling interests $ (13,054) $ (25,983)
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustments 1,726 (2,186)
Unrealized Gain (Loss) on Cash Flow Hedging Instruments (3,035) 682
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent (1,309) (1,504)
Comprehensive loss attributable to Stratasys Ltd. (14,363) (27,487)
Products    
Revenues    
Total net sales 93,795 99,196
Cost of revenues    
Total cost of sales 47,268 49,757
Service [Member]    
Revenues    
Total net sales 42,251 44,854
Cost of revenues    
Total cost of sales $ 28,539 $ 30,396